Home › Spinal Cord Injuries › NCT07433959
Neuromodulation to Improve Grasping Function After SCI
Neuromodulation to Improve Grasping Function After Spinal Cord Injury
Who can join
Ages 18 to 75 · All sexes · Healthy volunteers welcome
Full eligibility criteria
Inclusion Criteria: For individuals with SCI: * Ages 18-75 years * Chronic SCI (≥1 year of injury) * Cervical injury at C8 or above * Individuals who have MEP responses in at least one FDI muscle Exclusion Criteria: * Uncontrolled medical problems including pulmonary or cardiovascular disease * Premorbid, ongoing major depression or psychosis, altered cognitive status * History of head injury or stroke * Metal plate in skull * History of seizures * Receiving drugs acting primarily on the central nervous system, which lower the seizure threshold such as antipsychotic drugs * Pregnant females * Individuals who suffer from a spinal cord disease such as spinal stenosis, spinal bifida or herniated cervical
About the study
The goal of this study is to restore the activities of late descending signals with a noninvasive stimulation approach in combination with hand motor training to improve hand function in persons with cervical SCI. The main question it aims to answer is if the inputs to late descending signals above the level of injury and the output of residual late descending signals below the level of injury could be increased. Specifically, in the first part of the study, 30 participants will complete 2 randomized sessions to compare the effect of intermittent theta burst stimulation combined with paired corticospinal motoneuronal stimulation. In the second part of the study, 24 participants will complete either combined stimulation protocol or sham stimulation protocol with exercise training.
What is being tested
- iTBS (other)
- Sham iTBS (other)
- PCMS (other)
- Sham PCMS (other)
- Exercise (behavioral)
Sponsor: State University of New York at Buffalo · Participants: 54 · Started: Apr 1, 2026
Contact the study team
- Hang Jin Jo, PhD · Phone: 716-829-2905
Official record on ClinicalTrials.gov — NCT07433959
Locations in the U.S.
| New York | The State University of New York at Buffalo, Buffalo |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.